InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the detailed record of transactions filed by Puri Raj K.. Insider active across 1 company, notably Iovance Biotherapeutics, INC.. Cumulatively, 13 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €9k. Activity tracked since 16 December 2024. The latest transaction was disclosed on 8 September 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 条申报中的 13 条
Puri Raj K. is a declarant linked to Iovance Biotherapeutics, INC., where he is Chief Regulatory Officer. He has filed 9 forms in total, and across the recent filings observed from 2024-12-18 to 2026-03-06, the recorded activity shows EUR 8636 of buys and EUR 0 of sells, with the transaction nature noted as option exercise.